[Home ]   [ فارسی ]  
Main Menu
About The Association::
Contact Us::
News & Events::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: LabMedica Int'l e-Newsletter for October 15, 2010 ::
Screening Method Developed for River Blindness
Scientists have developed a screening method that rapidly identifies individuals with active river blindness, or onchocerciasis. More..

Molecular Screening Test Detects Colorectal Cancer
A ribonucleic acid screening assay detected the majority of early-stage colorectal cancers with good specificity and sensitivity. More..

Analyzers and Laboratory Information Systems Linked Through Single Workstation
A data management system links analyzers and laboratory information systems through a single workstation, providing technicians with a comprehensive real-time view of the clinical laboratory testing lifecycle. More..

Biomarker Panel Shows Promise for Prostate Cancer Diagnosis
Preliminary data on the development of a panel of biomarkers for the diagnosis of prostate cancer appears to be highly significant. More..

Conference to Deal with MS Application in Clinical Labs
The American Association for Clinical Chemistry has announced that a one-day conference, Practical Applications of Mass Spectrometry in the Clinical Laboratory, will be held on November 15, 2010, in Baltimore. More..

AWT IMAGESpotlight on Business
BD Diagnostics Collaborate With Bruker to Improve Microbial Identification
BD Diagnostics announced a development and marketing collaboration with Bruker Daltonics to promote an integrated approach to bacterial and fungal identification and antimicrobial susceptibility testing. More..


Use of Molecular Assays for HIAs Growing Rapidly
Molecular tests that can quickly identify hospital- acquired infections are rapidly becoming more popular. More..
Related topics Related topics
Print version Print version
Send to friends Send to friends

View: 3140 Time(s)   |   Print: 1306 Time(s)   |   Email: 178 Time(s)   |   0 Comment(s)